Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Current Assets: 2020-2021

Historic Current Assets for Design Therapeutics (DSGN) over the last 1 years, with Sep 2021 value amounting to $395.3 million.

  • Design Therapeutics' Current Assets was N/A to $395.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $395.3 million, marking a year-over-year change of. This contributed to the annual value of $36.2 million for FY2020, which is N/A change from last year.
  • As of Q3 2021, Design Therapeutics' Current Assets stood at $395.3 million, which was down 2.37% from $404.9 million recorded in Q2 2021.
  • Design Therapeutics' 5-year Current Assets high stood at $411.8 million for Q1 2021, and its period low was $36.2 million during Q4 2020.
  • In the last 2 years, Design Therapeutics' Current Assets had a median value of $400.1 million in 2021 and averaged $312.0 million.